Built for Academic Research
Institutional-grade clinical trial software with academic friendly pricing. Run investigator initiated trials with the same tools used by global pharma.
The Challenges You Face
Limited IT Resources
Academic institutions rarely have dedicated clinical trial IT teams. Setting up, validating, and maintaining trial technology falls to already-stretched research staff.
Budget Constraints
Commercial CTMS and EDC platforms are priced for pharma budgets. Academic-funded trials need enterprise capabilities at a fraction of the cost.
Regulatory Burden
Investigator-initiated trials face the same regulatory requirements as industry trials, but with fewer compliance resources and less vendor support.
Data Quality Concerns
Paper-based and spreadsheet workflows introduce errors, lack audit trails, and create problems during regulatory inspections and publication peer review.
Multi Center Coordination
Coordinating across university hospitals and research sites without standardized systems leads to protocol inconsistencies and data heterogeneity.
How Vitruvian Shield Helps
Academic Pricing
Dedicated academic licensing with volume based pricing, grant compatible invoicing, and no per patient surprises. Enterprise features at academic budgets.
Zero IT Required
Cloud-hosted, fully managed, and pre-validated. Your research team can configure and launch a study without any IT department involvement.
Compliance Out of the Box
ICH E6(R3) GCP, GDPR, and 21 CFR Part 11 compliance built in. Automated audit trails, eSignatures, and regulatory ready exports from day one.
Publication-Ready Data
CDISC compliant data exports, statistical analysis integration, and data quality reports that satisfy journal reviewers and regulatory inspectors alike.
Multi Center Made Easy
Standardized protocols, centralized data management, and role based access control across all participating institutions, from a single platform instance.
Let's Talk
Choose the path that fits your organization. Each route goes directly to the right internal owner.